NASD · Healthcare · Biotechnology · Canada
Edesa Biotech Inc is a micro cap company (market value under $300 million) in the Biotechnology industry.
Edesa Biotech is a biopharmaceutical company developing treatments for inflammatory and immune-related diseases. The company's pipeline includes drug candidates for vitiligo and allergic contact dermatitis in Medical Dermatology, and acute respiratory distress syndrome in Respiratory. Its candidates were acquired from other organizations and have shown clinical validation.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Edesa Biotech Inc stock.
Not valued: We cannot value this company yet.
134 more in this industry show a wider margin of safety.
We do not publish a verdict on EDSA yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.